A follow-up confirmatory study similarly identified 90% (36/40) OMM samples to express PD-L1, and importantly demonstrated that tumor-infiltrating lymphocytes, both CD4+ and CD8+, expressed PD-1 (89). This evidence concerns the gene CD274 and neoplasm.